| The life sciences industry, one of the pandemic's fastest-growing commercial real estate sectors, is now facing a sharp slowdown in demand as biotech firms grapple with economic pain. Developers in the industry's largest hub, Boston and Cambridge, say they are having a hard time leasing their buildings as growth has begun to drop off in recent months, executives said Tuesday at Bisnow's Boston Life Sciences Real Estate Conference at 33-41 Farnsworth St. 
As macroeconomic factors put pressure on small biotech companies to re-evaluate growth strategies — and as one of the sector's biggest banking partners has collapsed — the biotech market in Boston and around the country is facing a daunting challenge: leasing up the available space and the millions of square feet of new construction that are…  Read the full story here. | | |
